JOEL BOLEN: Open Payments
NPI 1063576130 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 11 payments from 9 companies in 2025. Trend: 2023 $322 · 2024 $388 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $68 |
| Alpha Cognition USA, Inc. | 1 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| SK Life Science, Inc. | 1 | $30 |
| Biogen, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Verona Pharma, Inc. | 1 | $16 |
Products named: EVENITY, Zunveyl, AUSTEDO XR, REXULTI, LEQEMBI, XTAMPZA, CREXONT, Ohtuvayre.
Industry payments across AL — which companies pay providers there.
